Total Holdings
35
As of Oct 4, 2026
AdvisorShares Psychedelics ETF
PSILNYSEARCAAdvisorSharesEquity
$20.64Today:- (-)1Y +7.74%
As of Oct 23, 2026 close
- Assets (AUM)
- $49.85M
- Expense ratio
- 1.00%
- Dividend yield
- 8.05%
- Holdings
- 35
- 52-week range
- $15.64$27.02
- Volume (live)
- -
- Avg. volume (3M)
- 26.53K
PSIL ETF Holdings: AdvisorShares Psychedelics ETF
Every listed position with its portfolio weight, plus sector breakdown and geographic exposure for this Equity ETF. Analyze fund diversification and concentration.
Top 10 Holdings
72.0%
Share of fund assets
Assets (AUM)
$49.85M
Total fund assets
Expense Ratio
1.00%
Annual management fee
Portfolio Allocations
Distribution breakdown by sector, asset type, and geographic region. Understand the fund's diversification strategy across markets and asset classes.
Loading chart...
Top 31 of 35 PSIL Holdings by Portfolio Weight
Holdings as of Oct 4, 2026. Ticker, name, asset type and portfolio weight for each position. Fund disclosures available to us list the largest 31 positions.
Scroll to see more
| # | Symbol | Name | Type | Weight |
|---|---|---|---|---|
| 1 |  | Definium Therapeutics, Inc. | Stock | 11.82% |
| 2 |  | ATAI Life Sciences BV | Stock | 11.50% |
| 3 |  | COMPASS Pathways plc | Stock | 11.45% |
| 4 | NEO:HELP | Helus Pharma Inc. | Stock | 8.87% |
| 5 |  | Neurocrine Biosciences, Inc. | Stock | 4.81% |
| 6 |  | ANRO | Stock | 4.76% |
| 7 |  | Relmada Therapeutics, Inc. | Stock | 4.72% |
| 8 |  | Neuronetics Inc | Stock | 4.70% |
| 9 |  | Eli Lilly and Company | Stock | 4.69% |
| 10 |  | AbbVie Inc. | Stock | 4.68% |
| 11 |  | NRX Pharmaceuticals Inc | Stock | 4.67% |
| 12 |  | GH Research PLC | Stock | 4.49% |
| 13 |  | Johnson & Johnson | Stock | 4.33% |
| 14 | CSE:DRUG | Bright Minds Biosciences Inc. | Stock | 3.95% |
| 15 |  | Bright Minds Biosciences Inc | Stock | 3.81% |
| 16 |  | Alkermes plc | Stock | 3.68% |
| 17 |  | Seaport Therapeutics, Inc. | Stock | 3.39% |
| 18 |  | Supernus Pharmaceuticals, Inc. | Stock | 3.26% |
| 19 | CSE:QNTM | Quantum BioPharma Ltd. | Stock | 2.69% |
| 20 |  | Psyence Biomedical Ltd. | Stock | 2.61% |
| 21 | OPTI.NE | Optimi Health Corp | Stock | 2.30% |
| 22 |  | Neuphoria Therapeutics Inc. | Stock | 2.12% |
| 23 |  | Optimi Health Corp. Common Shares | Stock | 1.85% |
| 24 |  | Pasithea Therapeutics Corp. | Stock | 1.21% |
| 25 |  | Incannex Healthcare Inc. | Stock | 1.06% |
| 26 |  | IGC Pharma, Inc. | Stock | 0.50% |
| 27 | TSX:NUMI | Numinus Wellness Inc. | Stock | 0.46% |
| 28 | NYSE MKT:IGC | India Globalization Capital Inc | Stock | 0.42% |
| 29 |  | Silo Pharma Inc | Stock | 0.37% |
| 30 |  | VistaGen Therapeutics Inc | Stock | 0.23% |
| 31 |  | Clearmind Medicine Inc. Common Shares | Stock | 0.00% |
Source: Fund holdings disclosures. Data as of Oct 4, 2026. Data sources and methodology
Frequently Asked Questions About AdvisorShares Psychedelics ETF Holdings
What are the top holdings in PSIL?
As of Oct 4, 2026, AdvisorShares Psychedelics ETF (PSIL) holds 35 securities. The largest are Definium Therapeutics, Inc. (11.82%), ATAI Life Sciences BV (11.50%), COMPASS Pathways plc (11.45%). The holdings table lists each position by portfolio weight with its ticker, name and asset type.
How concentrated is PSIL's portfolio?
As of Oct 4, 2026, the 10 largest positions make up 72.0% of PSIL's assets. A concentrated portfolio has fewer large positions with higher individual weights, while a diversified portfolio distributes holdings more evenly.
What is PSIL's sector allocation?
The Sector Allocation chart shows how PSIL distributes investments across different industries like Technology, Healthcare, Financials, and more. This sector exposure helps understand the fund's industry diversification strategy.
What countries does PSIL invest in?
PSIL's geographic exposure is shown in the Countries tab under Portfolio Allocations. This reveals the fund's international diversification and exposure to different regions and global markets.
How diversified is PSIL ETF?
PSIL's diversification can be assessed by reviewing its 35 holdings (as of Oct 4, 2026), sector allocation, and geographic exposure. A well-diversified ETF spreads investments across multiple securities, sectors, and regions to reduce concentration risk.